Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial

Ítems similars

• Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial
  per: Yang, Xu, et al.
  Publicat: (2021)
• Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score‐matched analysis
  per: Li, Chen, et al.
  Publicat: (2021)
• Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non–Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial
  per: Bi, Nan, et al.
  Publicat: (2019)
• A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer
  per: Li, Chen, et al.
  Publicat: (2019)
• Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases
  per: Liu, Lipin, et al.
  Publicat: (2015)